[Ebola, the day after].

Ebola, the day after A total of 28,616 cases (confirmed, probable, and suspected) and 11,310 deaths were reported in Guinea, Liberia, and Sierra Leone from March 2014 to June 2016. At first, the clinical picture dominated by severe gastroenteritis baffled clinicians trained to diagnose viral hæmorrhagic fever based on bleeding. And there was another problem: samples had to be sent abroad for laboratory confirmation of the diagnosis.

User Feedback on the MSF Tele-Expertise Service After a 4-Year Pilot Trial - A Comprehensive Analysis.

We surveyed all users of the Médecins Sans Frontières (MSF) tele-expertise service, approximately four years after it began operation. The survey contained 50 questions and was sent to 294 referrers and 254 specialists. There were 163 responses (response rate 30%).

The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment.

Background: In 1975-99, only 1·1% of new therapeutic products had been developed for neglected diseases. Since then, several public and private initiatives have attempted to mitigate this imbalance. We analysed the research and development pipeline of drugs and vaccines for neglected diseases from 2000 to 2011.

A large-scale distribution of milk-based fortified spreads: evidence for a new approach in regions with high burden of acute malnutrition.

Background: There are 146 million underweight children in the developing world, which contribute to up to half of the world's child deaths. In high burden regions for malnutrition, the treatment of individual children is limited by available resources. Here, we evaluate a large-scale distribution of a nutritional supplement on the prevention of wasting.